newsfilter
← Latest News
GlobeNewswire·

Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares

Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares PARIS, France, July 24, 2025 – 2:30 p.m. (CEST) – Abivax SA (PARIS:FR) ("Abivax" or the "Company"), a clinical-stage biotechnology